【辉瑞旗下药物Adcetris获FDA扩大癌症治疗批准】美国食品药物管理局(FDA)扩大辉瑞公司旗下药物Adcetris的批准范围,允许其用于治疗部分类型的淋巴瘤。该公司表示,继先前两种治疗方法之后,Adcetris可与其他药物合并使用,用于治疗复发或难治性大B细胞淋巴瘤。

金融界
13 Feb
美国食品药物管理局(FDA)扩大辉瑞公司旗下药物Adcetris的批准范围,允许其用于治疗部分类型的淋巴瘤。该公司表示,继先前两种治疗方法之后,Adcetris可与其他药物合并使用,用于治疗复发或难治性大B细胞淋巴瘤。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10